董事会认为，建议出售事项有助于减轻出售集团对集团造成的财务负担。鉴于出售集团连续多年录得亏 损并处于净负债状态，董事会认为，建议出售事项将释放集团塬本需投放于出售集团的流动资金，从而 使资源能够更有效率地分配至本集团其余业务，即烟草香精业务。 据悉，出售公司透过其多间于英属处女群岛及香港註册成立的直接及间接全资附属公司(其主要业务为 投资控股)持有九间于中国成立的附属公司的全部股权。该等于中国成立的附属公司主要于中国北京从 事提供财务担保、贷款融资、小额贷款、贷款转介及谘询服务，且于北京持有融资担保业务许可证及贷 款融资业务许可证。然而，由于出售集团的业务受到中国经济及营商环境的不利影响，其于北京的贷款 融资业务已完全停止，出售集团自2024年起一直暂无营业。 大中华金融(00431)公布，于2026年2月27日，该公司拟向妥光雄先生出售和锋有限公司全部已发行股 本，代价为1.00港元。 ...

智通财经APP讯，大中华金融(00431)公布，于2026年2月27日，该公司拟向妥光雄先生出售和锋有限公 司全部已发行股本，代价为1.00港元。 董事会认为，建议出售事项有助于减轻出售集团对集团造成的财务负担。鉴于出售集团连续多年录得亏 损并处于净负债状态，董事会认为，建议出售事项将释放集团塬本需投放于出售集团的流动资金，从而 使资源能够更有效率地分配至本集团其余业务，即烟草香精业务。 据悉，出售公司透过其多间于英属处女群岛及香港註册成立的直接及间接全资附属公司(其主要业务为 投资控股)持有九间于中国成立的附属公司的全部股权。该等于中国成立的附属公司主要于中国北京从 事提供财务担保、贷款融资、小额贷款、贷款转介及谘询服务，且于北京持有融资担保业务许可证及贷 款融资业务许可证。然而，由于出售集团的业务受到中国经济及营商环境的不利影响，其于北京的贷款 融资业务已完全停止，出售集团自2024年起一直暂无营业。 ...

Group 1 - The core announcement is that Pizu Industrial, a wholly-owned subsidiary of the company, has entered into a loan agreement with Kanzi Diyor, agreeing to provide a loan with a principal limit of up to $80 million, subject to the actual disbursement amount [1]

Core Viewpoint - Haosen Financial Technology (03848) has announced a loan financing agreement with Huizhou Wanyelung Glass Technology Co., Ltd., involving a loan amount of RMB 14.66 million at an annual interest rate of 21.6% for a duration of 12 months [1] Group 1 - The loan amount is RMB 14.66 million, which is approximately 2.1 million USD [1] - The annual interest rate for the loan is set at 21.6%, reflecting the financial background of the borrower and current market conditions [1] - The loan agreement is established for a term of 12 months, indicating a short-term financing strategy [1]

Core Viewpoint - Haosen Financial Technology (03848.HK) announced a loan financing agreement with a borrower, amounting to RMB 14.66 million (approximately HKD 16.51 million) with an annual interest rate of 21.6% for a term of 12 months [1] Group 1 - The loan amount is RMB 14.66 million, equivalent to approximately HKD 16.51 million as of the announcement date [1] - The annual interest rate for the loan is set at 21.6% [1] - The loan agreement is established for a duration of 12 months [1] Group 2 - The interest rate was determined based on the borrower's financial background, previous lending assessments, the lender's funding costs, and prevailing market rates [1]

Core Viewpoint - Haosen Financial Technology (03848) has announced a loan financing agreement with Huizhou Wanyelong Glass Technology Co., Ltd., amounting to RMB 14.66 million at an annual interest rate of 21.6% for a term of 12 months [1] Group 1 - The loan amount is RMB 14.66 million, which is approximately USD 2.1 million [1] - The annual interest rate for the loan is set at 21.6%, reflecting the financial background of the borrower and current market conditions [1] - The loan agreement is established for a duration of 12 months, starting from the date of the agreement [1]

Core Viewpoint - The company is undergoing a significant restructuring by selling its indirect wholly-owned subsidiary, China Hengjia Capital Group Co., Ltd., to address ongoing litigation and operational challenges, with the sale price set at RMB 70 million [1][2]. Group 1: Sale Agreement and Financial Implications - The sale agreement involves the seller, a wholly-owned subsidiary of the company, and the buyer, Sheen Nation Holdings Limited, with the transaction aimed at resolving disputes related to Hong Kong Hengjia [1]. - China Hengjia Capital Group primarily engages in investment holding and financial leasing, holding approximately 51.39% equity in Beijing Hengjia, which has faced operational losses due to stricter regulatory frameworks and challenging market conditions [1]. - The company lost actual control over Beijing Hengjia since August 2023 due to disputes with its Chinese joint venture partner, leading to operational deadlock and ongoing litigation [1]. Group 2: Litigation and Strategic Exit - The board has considered various solutions, including potential judicial liquidation, which could take years and incur substantial legal costs without guaranteed compensation [2]. - The ongoing litigation from Beijing Hengjia demands the company to cover approximately $20 million in unpaid capital contributions, making the sale a strategic exit to eliminate uncertainties related to the lawsuit [2]. - The sale allows the company to focus on its core business lines and utilize the proceeds to expand its loan financing and securities investment operations in Hong Kong, as well as enhance its distribution of healthcare, pet products, and health food manufacturing [2].

Core Viewpoint - The company is undergoing a significant restructuring by selling its indirect wholly-owned subsidiary, China Hengjia Capital Group Co., Ltd., to address ongoing litigation and operational challenges, with the sale price set at RMB 70 million [1][2]. Group 1: Sale Agreement and Financial Details - The sale agreement involves the seller, a wholly-owned subsidiary of the company, and the buyer, Sheen Nation Holdings Limited, with the transaction valued at RMB 70 million [1]. - China Hengjia Capital Group primarily engages in investment holding and financial leasing, holding approximately 51.39% of Beijing Hengjia's equity, classified as equity investments measured at fair value through other comprehensive income [1]. Group 2: Operational Challenges and Litigation - The subsidiary has faced operational losses in recent years due to stricter regulatory frameworks and challenging market conditions in China [1]. - Since August 2023, the company lost actual control over Beijing Hengjia due to disputes with its Chinese joint venture partner, leading to operational stagnation and ongoing litigation [1]. Group 3: Strategic Implications of the Sale - The board has considered various solutions, including potential judicial liquidation, but found them uncertain and costly, prompting the decision to proceed with the sale as a means to eliminate litigation-related uncertainties [2]. - The sale provides an immediate exit opportunity to divest non-core underperforming assets and allows the company to focus on more promising and manageable business lines [2]. - Proceeds from the sale are intended to be used to expand the company's loan financing and securities investment business in Hong Kong, as well as to enhance operations in healthcare, pet products distribution, and health food manufacturing and sales [2].

Group 1 - The core point of the article is that Haosen Financial Technology (03848) has entered into a loan financing agreement with borrower Deng Jianhua, involving a loan amount of RMB 33.3 million at an annual interest rate of 9% for a term of 15 months, starting from the date of the agreement [1] Group 2 - The loan financing agreement is established through Haosen's indirect wholly-owned subsidiary, Haosen Microfinance [1] - The agreement is set to mature on December 17, 2025, indicating a medium-term financial commitment [1] - The interest rate of 9% reflects the company's pricing strategy in the microfinance sector [1]

Group 1 - The core announcement is that Haosen Financial Technology (03848) has entered into a loan financing agreement with borrower Deng Jianhua, involving a loan amount of RMB 33.3 million [1] - The loan carries an annual interest rate of 9% and is set for a duration of 15 months from the date of the agreement [1]